APA (7th ed.) Citation

Piccicacco, N., Zeitler, K., Ing, A., Montero, J., Faughn, J., Silbert, S., & Kim, K. (2022). Real-world effectiveness of early remdesivir and sotrovimab in the highest-risk COVID-19 outpatients during the Omicron surge. Journal of antimicrobial chemotherapy, 77(10), 2693-2700. https://doi.org/10.1093/jac/dkac256

Chicago Style (17th ed.) Citation

Piccicacco, Nicholas, Kristen Zeitler, Austin Ing, Jose Montero, Jonathan Faughn, Suzane Silbert, and Kami Kim. "Real-world Effectiveness of Early Remdesivir and Sotrovimab in the Highest-risk COVID-19 Outpatients During the Omicron Surge." Journal of Antimicrobial Chemotherapy 77, no. 10 (2022): 2693-2700. https://doi.org/10.1093/jac/dkac256.

MLA (9th ed.) Citation

Piccicacco, Nicholas, et al. "Real-world Effectiveness of Early Remdesivir and Sotrovimab in the Highest-risk COVID-19 Outpatients During the Omicron Surge." Journal of Antimicrobial Chemotherapy, vol. 77, no. 10, 2022, pp. 2693-2700, https://doi.org/10.1093/jac/dkac256.